Tech Company Financing Transactions

Octarine Bio Funding Round

On 11/2/2023, Octarine Bio raised $4.6 million in funding from DSM Venturing, Oskare Capital and The Footprint Firm.

Transaction Overview

Company Name
Announced On
11/2/2023
Transaction Type
Venture Equity
Amount
$4,620,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Ole Maaløes Vej 3, København N
Capital Region, 2200
DK
Phone
Undisclosed
Email Address
Overview
Octarine is unlocking the power of biology to deliver innovative cannabinoid and psychedelic therapeutics
Profile
Octarine Bio LinkedIn Company Profile
Social Media
Octarine Bio Company Twitter Account
Company News
Octarine Bio News
Facebook
Octarine Bio on Facebook
YouTube
Octarine Bio on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Nethaji Gallage
  Nethaji Gallage LinkedIn Profile  Nethaji Gallage Twitter Account  Nethaji Gallage News  Nethaji Gallage on Facebook
Chief Financial Officer
Jan Villadsen
  Jan Villadsen LinkedIn Profile  Jan Villadsen Twitter Account  Jan Villadsen News  Jan Villadsen on Facebook
Chief Scientific Officer
Nicholas Milne
  Nicholas Milne LinkedIn Profile  Nicholas Milne Twitter Account  Nicholas Milne News  Nicholas Milne on Facebook


 

 

Browse more venture capital transactions:

Prev: 11/2/2023: Accelex venture capital transaction
Next: 11/2/2023: Kuva Space venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary